PGY1 Course Description

Similar documents
PGY1: Pediatric Infectious Diseases Riley Hospital for Children Indiana University Health

Infectious EUH Learning Activities:

Antimicrobial EUHM Learning Activities:

PGY 1 Pharmacy Residency Cardiology Experience Description Truman Medical Center Hospital Hill

PGY1: Pediatric Cardiovascular Intensive Care Unit Riley Hospital for Children at Indiana University Health

Acute Care Cardiology Learning Description at Emory University Hospital Midtown (EUHM)

Neonatal Intensive Care Unit EUHM

ROTATION DESCRIPTION FORM PGY1

Stellar Hospital PGY-1 Pharmacy Residency

ROTATION DESCRIPTION

ROTATION DESCRIPTION - PGY1 Adult Internal Medicine

PGY1 Infectious Disease Longitudinal Rotation

University of Utah PGY-1 Pharmacy Practice Primary Care: Ambulatory I & II Rotation Salt Lake City, Utah

Medical Intensive Care Unit Rotation EUHM

Neurocritical Care Rotation - EUH

Liver EUH Learning Activities:

Neurology Clinic - Ambulatory Care I & II

1. General description

PGY1 Oncology Rotation

Mission: To extend the presence and healing ministry of Christ in all we do.

Rotation Name: DHMC ID Consultation

Liver Transplant EUH Learning Activities:

Department of Pharmacy Services PGY1 Residency Program. Residency Manual

PGY1 Medication Safety Core Rotation

The implementation of a clinical training program for staff pharmacists

Pharmacy Leadership and Administration Learning Experience Rev 12/16/16

PGY1 Oncology 2 Advanced Learning Experience

PGY2 AMBULATORY CARE PHARMACY RESIDENCY MEDICAL UNIVERSITY OF SOUTH CAROLINA

Infectious Diseases Elective PL1 Residents

Decreasing Readmissions in Outpatient Parenteral AntImicrobial Therapy (DROP IT)

Block Title: Patient Care Experience Block #: PHRM 701, 702, 703, 704 and PHRM 705, 706, and 707 (if patient care)

Transition of Care Practices. Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit, MI

Board of Pharmacy Specialties Portfolio Requirements for Added Qualifications in Infectious Diseases Pharmacotherapy

MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative

Learning Experiences Descriptions

The Core Elements of Antibiotic Stewardship with CMS and QAPI Updates

Transition of Care Practices. Nancy MacDonald, PharmD, BCPS, FASHP Henry Ford Hospital Detroit

Session 74X Leveraging Your Hospital's Hidden Assets to Drive Meaningful Change

Internal Medicine Curriculum Infectious Diseases Rotation

Antimicrobial Stewardship Program in the Nursing Home

Disclosures. Objectives. Leveraging and Developing Your Team for Optimal Outcomes. None

APPE Acute Care Rotation Evaluation of Student

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016

Postgraduate Year One (PGY1) Pharmacy Residency Program

Bethesda Hospital PGY1 Residency Program Learning Experiences

PGY-1 Pediatric Pharmacy Residency Program PhORCAS Program Code

Pathophysiology Curriculum

Home Infusion (elective)

OPINION PAPER. (Pre-publication Draft)

Informatics and Technology (elective)

Educational Outcomes, Goals, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Internal Medicine

Preceptor Development: Patient Care Process. The Pharmacy Care Plan

Florida A&M University College of Pharmacy & Pharmaceutical Sciences

A Game Plan to Surviving a Joint Commission Survey. May Adra, BS Pharm, PharmD, BCPS

Innovation in Self-Care

Understanding Antimicrobial Stewardship: Is Your Organization Ready? A S H LEIGH MOUSER, PHARM D, BCPS

Supply Chain Management

Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.

Community Pharmacy Advanced Pharmacy Practice Experience SPPS 402

Post-Test/ Evaluation

University of Virginia Health System Department of Pharmacy Services PGY2 Drug Information Residency Residency Purpose Statement

American Journal of Pharmaceutical Education 2003; 67 (3) Article 88.

Required Educational Outcomes, Goals, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Solid Organ Transplant

Park Nicollet Medication Management

PGY-1 Pharmacy Practice

PHARMACY PRACTICE. Residency Program

Required Experiences. Academia/Teaching Experience

Impact of a Pharmacist-managed, Studentsupported Inpatient Warfarin Education Program on HCAHPS Scores in a Community Teaching Hospital

Structure of SJRMC PGY2 Ambulatory Care Residency Learning Experiences

Prepared Jointly by the American Society of Health-System Pharmacists and the Academy of Managed Care Pharmacy

House Staff Orientation Department of Pharmacy

Ambulatory Care Advanced Pharmacy Practice Experience SPPS 401A SPPS 401B

Practice Tools for Safe Drug Therapy

Today s webinar will begin in a few minutes.

ASHP Accredited PGY1 & PGY2 Residency with Master s Degree in Health-System Pharmacy Administration

Stanford Multiorgan Transplant Surgery: R-1 Tuesday, February 02, 2016

SJMH Pharmacy Services. Chris Manthey, Pharm D Director, Clinical Pharmacy Services

Background and Methodology

PRE-SURVEY QUESTIONNAIRE AND SELF-ASSESSMENT CHECKLIST FOR THE ACCREDITATION OF A POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCY PROGRAM

Inaugural Three Rivers Antimicrobial Stewardship Symposium

Educational. PPCP Foundations 3/5/17. Integrating the LLM / JCPP-PPCP in Experiential Education. Session Objectives

UNDERSTANDING THE CONTENT OUTLINE/CLASSIFICATION SYSTEM

FERRIS STATE UNIVERSITY COLLEGE OF PHARMACY APPROVED BY FACULTY AUGUST 20, 2014

7:30 a.m. 8:05 a.m. Welcome/Introductions and Tips for Success

Experiential Education

ROTATION DESCRIPTION FORM PGY2 CRITICAL CARE

RULE RESPONSIBILITIES OF A PHYSICIAN WHO ENGAGES IN DRUG THERAPY MANAGEMENT WITH A COLORADO LICENSED PHARMACIST

Journey to a Successful Antibiotic Stewardship Program in a Small Rural Healthcare Facility

Implementation of Clinical Services at Various Institutions

Required Experiences. Academia/Teaching Experience. Administration Experience Required Longitudinal Site(s) FMC, Hospital

Drug EUHM Learning Activities:

EVIDENCE-BASED REVIEW PROCESS FOR FORMULARY DRUG ADDITION

Incorporating the Pharmacists Patient Care Process into Practice

ELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES

Integrating the LLM / JCPP-PPCP Seena Haines, PharmD, BCACP, FASHP, FAPhA, BC-ADM, CDE Jenny A. Van Amburgh, PharmD, RPh, FAPhA, BCACP, CDE

THE JCPP PHARMACISTS PATIENT CARE PROCESS: TIME TO REINVENT THE WHEEL?

Monitoring Medication Storage & Administration

ROTATION DESCRIPTION

PGY1 PHARMACY RESIDENCY PROGRAM MANUAL BETH ISRAEL DEACONESS MEDICAL CENTER BOSTON, MASSACHUSETTS

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center

Transcription:

PGY1 Course Description Learning Experience Title: Infectious Disease Preceptor: Name: Sayo Weihs, Pharm.D, MBA, BCPS Antimicrobial Stewardship Pharmacist Truman Medical Center-Hospital Hill Department of Pharmacy 2301 Holmes Kansas City, MO 64108 Phone: (816) 404-4216 Pager: (816) 864-3859 Fax: (816) 404-4199 Email: sayo.weihs@tmcmed.org Description: The primary purposes of this 4 week required core experience are to provide clinical pharmacy services for patients being seen by the infectious disease team. At the end of this experience, the resident should be able to determine the most appropriate antimicrobial for treatment at the most effective dose for common disease states. The pharmacist in this role on the infectious disease team is to be prepared for rounds, attend rounds, and provide additional information for patient care and teaching of residents, students, and fellows. Pharmacists need to follow up on questions from the team to develop patient plans and attend weekly ID meetings and provide feedback and comments. Pharmacists will manage the antimicrobial formulary, evaluate the need for non-formulary products and if a need occurs, procure product in an appropriate amount of time, evaluate discharge requests and assist with planning for infusion chair patients. Learning Experience Responsibilities: Attend ID rounds daily o Rounds can start at any time between 1030-1500 depending on attending on service Page the resident working with the ID team for rounding time o Be fully prepared prior to attending rounds Discuss patients with preceptor prior to rounds o Perform pharmaceutical care monitoring for all assigned patients on the ID team list A case presentation/drug presentation is required at the end of the month o At least 2 sources of primary literature to answer a clinical question o Depending on other activities may have projects instead of presentation but depends on resident and projects available Clinical Pearl for Staff

o At least one clinical pearl email to staff over rare drug/bacteria/disease state Attend Infection prevention, Antimicrobial Stewardship, and ID weekly meetings Formulary review/due o Some review will likely be required during your rotation and determined early in the month to allow plenty of time Precept any students or residents that happen to be on rotation with you during your rotation Meet to discuss patients and review readings Disease States: Disease states commonly encountered during this experience that the resident will be expected to review, discuss, and apply include but are not limited to: CNS infections Complicated intra-abdominal infections Infections in immunocompromised host Endocarditis Pneumonia Sepsis Wound infections Learning Experience Activities: Activity Accurately gather, organize, and analyze patient specific information on assigned patients prior to rounds and/or discussion with preceptor. Review profiles to identify medication-related problems to discuss with preceptor and then prescriber. Independently develop a therapeutic plan for rounds, and be able to verbalize the plan, and prove it is evidence based after evaluation of all available data from all available sources including patient, family, medical group and electronic data bases. For each individual patient, summarize important patient facts to preceptor and/or medical team during sit-down or bedside rounds Actively participate/follow up in team rounds daily. Based on potential medication related problems identified by working up your patients, be prepared to: Recommend solutions to identified problems Respond to drug information questions verbally Follow up on medication related problems identified Objectives Covered R1.1.3 R1.1.4 R1.1.5 R1.1.6

during rounds. Determine when the information is needed and assure you provide the follow up information within the appropriate time frame. Ensure medication orders are written appropriately (Drug, dose, route, frequency) Independently Complete monthly experience evaluations with written evidence of improving the quality of own performance. Convey expertise and professionalism in interactions with pharmacy and multidisciplinary staff by staying abreast of current literature and actively identifying opportunities for selfimprovement Use effective educational techniques when providing medication education to patients and/or caregivers Contribute to the education of or serve as preceptor (or copreceptor) to pharmacy students as appropriate. Provide inservices to staff, providing written material when applicable. Select and utilize the appropriate preceptor role(s) (direct instruction, modeling, coaching, or facilitation) based upon the learners skill level. 2. Perform patient and topic discussions with students, as appropriate Model interactions with the medical or nursing staff, or model a thought process for a student; If deemed appropriate by the resident and preceptor, assume the role of facilitator for the student. R3.1.2 R3.2.4 R4.1.1 R4.1.2 R4.2.1 R4.2.2 Objectives selected to be evaluated during learning experience: R1.1.4: (Analyzing) Analyze and assess information on which to base safe and effective medication therapy R1.1.5: (Creating) Design or redesign safe and effective patient-centered therapeutic regimens and monitoring plans (care plans) R3.1.2: (Applying) Apply a process of on-going self-evaluation and personal performance improvement R4.1.2: (Applying) Use effective presentation and teaching skills to deliver education R4.2.2: (Applying) Effectively employ preceptor roles, as appropriate Requirements of Learning Experience:

Expected hours: 0700-1600; these times may vary depending on patient census, service requirements, and attending on service. Required presentations: One formal presentation (drug review, patient case, etc) given to the pharmacy staff, but can change. Two sources of primary literature required. Required readings: Disease state discussions will focus on IDSA guidelines with supplementation of new research. These guidelines can be found at www.idsociety.org including Opportunistic infections (Cryptococcal meningitis, Pneumocystis, Histoplasmosis, HAP/VAP/CAP pneumonia, and more subjects based on patient population. Preceptor interaction: Meet with the preceptor on daily basis to discuss patient information, analysis and redesigned therapeutic plan. Topic discussions will be scheduled for weekly basis, unless chosen otherwise. Communication: Resident is expected to communicate independently with various primary teams during antimicrobial stewardship unless directed otherwise from preceptor. The communication of antimicrobial stewardship is based on provider education in mind, and should be collaborative. Expected progression of resident on this learning experience: Week 1-2: Look up all patients on the ID service before meeting with preceptor. As time progresses look up necessary lab work to determine diagnosis and then treatment of these patients. Some missing laboratory work is acceptable at this time as the resident is learning what material is important. The goal is resident to have the patient assessment and plan done before meeting with the preceptor. During these two weeks more discussion can occur to come to conclusions with a progression to a detailed assessment and plan with evidence based medicine backing it up. Lock down a topic for your presentation and start working on it. Week 3-4: Continue to look up patients before meeting with preceptor. At this point limited information should be missed regarding laboratory or clinical findings in infectious disease states. Assessment and plans should be developed with evidence based medicine backing before meeting with preceptor. Have the presentation completed several days before it s presented to have time to work on details and transitions. Method of Evaluation: Evaluation of the resident will be based on the ASHP activity learning experiences listed above. Each learning activity has a corresponding code following the experience which corresponds to the activity learning experience listed in PharmAcademic. During the orientation to the learning experience, the preceptor and the resident will review all the material contained in this learning experience description and sign a copy to be retained in the residents file.

The preceptor will provide feedback verbally (formative) throughout the course of the learning experience and electronically (summative) via PharmAcademic at the conclusion of the experience. Once the resident is finished with all of the requirements for the experience, the preceptor and the resident will discuss the learning experience as a whole both formally and informally. The resident will also be responsible for providing both formative and summative feedback at the conclusion of the experience. All evaluations must be submitted by the conclusion of the learning experience. I have read and acknowledged the responsibilities of the learning experience. Pharmacy Resident Primary Preceptor